MAOYAN ENT (01896.HK) announced its interim results for the period ending June this year, with a revenue of RMB 2.472 billion, an increase of 13.9% year-on-year. The net profit was RMB 178 million, a decrease of 37.3% year-on-year; earnings per share were RMB 0.16. No dividend was declared.
During the period, adjusted EBITDA decreased by 32% year-on-year to RMB 333 million; adjusted net profit decreased by 33.2% year-on-year to RMB 235 million

01896

MAOYAN ENT announced its interim results for the period ending June this year, with a revenue of RMB 2.472 billion, an increase of 13.9% year-on-year. The net profit was RMB 178 million, a decrease of 37.3% year-on-year; earnings per share were RMB 0.16. No dividend was declared. During the period, adjusted EBITDA decreased by 32% year-on-year to RMB 333 million; adjusted net profit decreased by 33.2% year-on-year to RMB 235 million

"Performance" MAOYAN ENT's net profit for the half year is 178 million yuan, a decrease of 37.3%